Literature DB >> 10708948

The Smad pathway.

J L Wrana1, L Attisano.   

Abstract

Transforming growth factor-beta superfamily member signals are conveyed through cell-surface serine/threonine kinase receptors to the intracellular mediators known as Smads. Activation of Smads causes their translocation from the cytoplasm to the nucleus where they function to control gene expression. In this review we will focus on proteins that modulate Smad activity, including SARA, for Smad Anchor for Receptor Activation, which functions during the initiation of signalling and on components of the ubiquitin-proteasome pathway, such as Smurf1, which can negatively regulate Smad signalling. In addition, we will summarize recent findings on the role of Smads as transcriptional co-modulators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708948     DOI: 10.1016/s1359-6101(99)00024-6

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  58 in total

1.  Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.

Authors:  M Weinstein; S P Monga; Y Liu; S G Brodie; Y Tang; C Li; L Mishra; C X Deng
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

3.  Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia.

Authors:  Claudia Rozenfeld; Rodrigo Martinez; Sérgio Seabra; Celso Sant'anna; J Gabriel R Gonçalves; Marcelo Bozza; Vivaldo Moura-Neto; Wanderley De Souza
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

Review 4.  Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

Authors:  W Wick; M Platten; M Weller
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.

Authors:  Rudolf A de Boer; Saraswati Pokharel; Markus Flesch; Derk A van Kampen; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen; Yigal M Pinto
Journal:  J Mol Med (Berl)       Date:  2004-08-20       Impact factor: 4.599

6.  Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Seong-Jin Kim; David Danielpour
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway.

Authors:  Jian Xiao; Qi Xiang; Ye-Chen Xiao; Zhi-Jian Su; Zhi-Feng Huang; Qi-Hao Zhang; Yi Tan; Xiao-Kun Li; Ya-Dong Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-04-23

8.  Developmental pathways during in vitro progression of human islet neogenesis.

Authors:  Rikke Dodge; Cindy Loomans; Arun Sharma; Susan Bonner-Weir
Journal:  Differentiation       Date:  2008-11-06       Impact factor: 3.880

9.  Activin betaA subunit, follistatin and follistatin-like 3 are expressed in the endometrium of ovariectomized rats and regulated by estrogen replacement.

Authors:  Márcia C Ferreira; Inês K D Cavallo; Pasquale Florio; Felice Petraglia; Fernando M Reis
Journal:  J Mol Histol       Date:  2008-09-09       Impact factor: 2.611

10.  TGF-beta inhibits IL-1beta-activated PAR-2 expression through multiple pathways in human primary synovial cells.

Authors:  Shin-Han Tsai; Ming-Thau Sheu; Yu-Chih Liang; Hsiu-Tan Cheng; Sheng-Shiung Fang; Chien-Ho Chen
Journal:  J Biomed Sci       Date:  2009-10-23       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.